Testing effectiveness (Phase 2)Study completedNCT01242488
What this trial is testing
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Who this might be right for
Rheumatoid Arthritis
UCB Pharma 221